• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成品输液储存时间的统计分析。

Statistical analysis of the storage time of finished product infusion.

机构信息

Pharmacy Department, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.

Clinical Research Center, Jiading District Central Hospital Affiliated to Shanghai University of Medicine & Health Sciences, Shanghai, China.

出版信息

J Int Med Res. 2024 Jan;52(1):3000605231222231. doi: 10.1177/03000605231222231.

DOI:10.1177/03000605231222231
PMID:38180889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10771069/
Abstract

OBJECTIVE

This retrospective study determined the storage time of finished infusion in each hospital ward and assessed whether the storage time of finished infusion was within an acceptable range.

METHODS

The research object was the finished infusion (one bag of infusion with only one drug) that is centrally dosed at the Pharmacy Intravenous Admixture Service (PIVAS) of Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences. We used an automatic scanner to assess the placement time of finished infusion products in various wards of the hospital. We classified the drugs used in various wards, analyzed whether their placement times were reasonable, assessed the reasons for unreasonable placement times, and took intervention measures. Similarly, the storage time of finished infusion was deemed reasonable or unreasonable, the reasons for unreasonable storage times were analyzed, and intervention measures were taken.

RESULTS

In September 2021, the proportion of infusions stored for an unreasonable time was 12.69%, a decrease of 5.37% compared with August 2021, indicating the effectiveness of intervention measures.

CONCLUSION

By using statistical analysis and intervention measures, our PIVAS improved the standardized use of finished infusion products and ensured the safety of medication for patients.

摘要

目的

本回顾性研究确定了每个医院病房中成品输液的储存时间,并评估了成品输液的储存时间是否在可接受范围内。

方法

研究对象为上海大学附属嘉定区中心医院药学静脉药物配置中心(PIVAS)集中调配的成品输液(一袋含一种药物的输液)。我们使用自动扫描仪评估医院各病房成品输液产品的放置时间。我们对各病房使用的药物进行分类,分析其放置时间是否合理,评估不合理放置时间的原因,并采取干预措施。同样,成品输液的储存时间被认为是合理或不合理的,分析不合理储存时间的原因,并采取干预措施。

结果

2021 年 9 月,不合理储存时间的输液比例为 12.69%,与 2021 年 8 月相比下降了 5.37%,表明干预措施有效。

结论

通过使用统计分析和干预措施,我们的 PIVAS 提高了成品输液产品的标准化使用,确保了患者用药的安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce31/10771069/424512889006/10.1177_03000605231222231-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce31/10771069/6593d701e439/10.1177_03000605231222231-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce31/10771069/424512889006/10.1177_03000605231222231-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce31/10771069/6593d701e439/10.1177_03000605231222231-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce31/10771069/424512889006/10.1177_03000605231222231-fig2.jpg

相似文献

1
Statistical analysis of the storage time of finished product infusion.成品输液储存时间的统计分析。
J Int Med Res. 2024 Jan;52(1):3000605231222231. doi: 10.1177/03000605231222231.
2
Application of information-intelligence technologies in pharmacy intravenous admixture services in a Chinese third-class a hospital.信息情报技术在中国三级甲等医院药学静脉药物配置服务中的应用。
BMC Health Serv Res. 2022 Oct 7;22(1):1238. doi: 10.1186/s12913-022-08580-4.
3
Real-world study of the leakage of two types of infusion bags in multicenter pharmacy intravenous admixture service (PIVAS).两种输液袋在多中心静脉药物配置中心(PIVAS)渗漏情况的真实世界研究。
Front Pharmacol. 2023 Oct 6;14:1273020. doi: 10.3389/fphar.2023.1273020. eCollection 2023.
4
Development of regional pharmacy intravenous admixture services data reporting and analysis platform for enhanced quality control ability.开发区域性药学静脉药物调配服务数据报告和分析平台,以提高质量控制能力。
BMC Health Serv Res. 2024 Feb 22;24(1):231. doi: 10.1186/s12913-024-10696-8.
5
Construction situation, costs and charges associated with pharmacy intravenous admixture services: multi-center cross-sectional survey based on 137 medical institutions in mainland China.药剂科静脉药物配置服务的建设情况、成本及收费:基于中国大陆 137 家医疗机构的多中心横断面调查。
BMC Health Serv Res. 2020 Jun 24;20(1):577. doi: 10.1186/s12913-020-05336-w.
6
Multi-center survey on the training status of staff working in pharmacy intravenous admixture services (PIVAS) in mainland China: Perspectives of PIVAS staff.中国大陆药学静脉药物配置服务(PIVAS)工作人员培训状况的多中心调查:PIVAS 工作人员的观点。
Medicine (Baltimore). 2021 Nov 5;100(44):e27676. doi: 10.1097/MD.0000000000027676.
7
Multi-center investigation on personnel training and scientific research status of pharmacy intravenous admixture services (PIVAS) in mainland China based on the perspectives of PIVAS leaders.基于静脉用药调配中心(PIVAS)负责人视角的中国大陆地区药学人员培训与科研现状的多中心调查
Medicine (Baltimore). 2021 Mar 12;100(10):e24881. doi: 10.1097/MD.0000000000024881.
8
Investigation on status and needs of pharmacy intravenous admixture service (PIVAS) personnel training: A qualitative focus group interview study.药学静脉药物配置服务(PIVAS)人员培训现状与需求调查:定性焦点小组访谈研究。
Medicine (Baltimore). 2023 Dec 15;102(50):e36309. doi: 10.1097/MD.0000000000036309.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Effect of a Pharmacy-based Centralized Intravenous Admixture Service on the Prevalence of Medication Errors: A Before-and-After Study.基于药房的集中静脉药物配置服务对用药错误发生率的影响:一项前后对照研究。
J Patient Saf. 2022 Dec 1;18(8):e1181-e1188. doi: 10.1097/PTS.0000000000001047. Epub 2022 Jun 30.

本文引用的文献

1
Studies on the optimization of decontamination protocol for surfaces contaminated with cytotoxic drugs in PIVAS.在 PIVAS 中,针对细胞毒性药物污染表面的去污方案优化进行研究。
J Oncol Pharm Pract. 2023 Oct;29(7):1565-1573. doi: 10.1177/10781552221138331. Epub 2022 Dec 21.
2
Cost analysis of implementing a vial-sharing strategy for chemotherapy drugs using intelligent dispensing robots in a tertiary Chinese hospital in Sichuan.在中国四川的一家三级医院中使用智能配药机器人实施化疗药物小瓶共享策略的成本分析。
Front Public Health. 2022 Sep 21;10:936686. doi: 10.3389/fpubh.2022.936686. eCollection 2022.
3
Establishment and validation of analytical methods for 15 hazardous drugs by UPLC-Q/Orbitrap-HRMS.
超高效液相色谱-四极杆/轨道阱高分辨质谱法测定15种危害药品分析方法的建立与验证
Ann Transl Med. 2022 Jun;10(12):686. doi: 10.21037/atm-22-2330.
4
Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.近年来改善非水溶性药物在无定形药物固体中溶解和过饱和的进展:综述。
AAPS PharmSciTech. 2021 Dec 10;23(1):16. doi: 10.1208/s12249-021-02137-0.
5
Multi-center survey on the training status of staff working in pharmacy intravenous admixture services (PIVAS) in mainland China: Perspectives of PIVAS staff.中国大陆药学静脉药物配置服务(PIVAS)工作人员培训状况的多中心调查:PIVAS 工作人员的观点。
Medicine (Baltimore). 2021 Nov 5;100(44):e27676. doi: 10.1097/MD.0000000000027676.
6
Recent Technologies for Amorphization of Poorly Water-Soluble Drugs.难溶性药物非晶化的最新技术
Pharmaceutics. 2021 Aug 23;13(8):1318. doi: 10.3390/pharmaceutics13081318.
7
Multi-center investigation on personnel training and scientific research status of pharmacy intravenous admixture services (PIVAS) in mainland China based on the perspectives of PIVAS leaders.基于静脉用药调配中心(PIVAS)负责人视角的中国大陆地区药学人员培训与科研现状的多中心调查
Medicine (Baltimore). 2021 Mar 12;100(10):e24881. doi: 10.1097/MD.0000000000024881.
8
Construction situation, costs and charges associated with pharmacy intravenous admixture services: multi-center cross-sectional survey based on 137 medical institutions in mainland China.药剂科静脉药物配置服务的建设情况、成本及收费:基于中国大陆 137 家医疗机构的多中心横断面调查。
BMC Health Serv Res. 2020 Jun 24;20(1):577. doi: 10.1186/s12913-020-05336-w.
9
Systematic Review on Infusion Reactions to and Infusion Rate of Monoclonal Antibodies Used in Cancer Treatment.癌症治疗中单克隆抗体输注反应和输注率的系统评价。
Anticancer Res. 2020 Mar;40(3):1201-1218. doi: 10.21873/anticanres.14062.
10
Chinese centralised intravenous admixture service (CIVAS), an emerging pharmaceutical industry: survey of the recent advances of CIVAS in China.中国集中式静脉药物配置服务(CIVAS):一个新兴的制药行业——中国CIVAS的最新进展调查
Eur J Hosp Pharm. 2018 May;25(3):165-168. doi: 10.1136/ejhpharm-2016-001154. Epub 2017 Mar 2.